Combination of topical tacrolimus ointment and NB-UVB for vitiligo on the face and neck

Journal of Clinical Dermatology

Volumn 39, Issue 2, 2010, Pages 127-129

  Suo, Dan Feng ^a   Zhang, Jun Ling ^a   Yan, Cui Yan ^a  

^a Medical University   (China)

Author keywords

NB UVB; Tacrolimus; Vitiligo

Indexed keywords

TACROLIMUS;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREAM; DRUG EFFECT; DRUG SAFETY; FACE; HUMAN; MAJOR CLINICAL STUDY; NECK; OINTMENT; OUTCOME ASSESSMENT; PHOTOGRAPHY; RANDOMIZED CONTROLLED TRIAL; SKIN COLOR; SKIN DEFECT; TREATMENT RESPONSE; ULTRAVIOLET B RADIATION; VITILIGO;

EID: 77950834712     PISSN: 10004963     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Lan CC, Chen GS, Chiou MH, et al. FK506 promotes melanocyte and melanoblast growth and creates a favourable milieu for cell migration via keratinocytes: possible mechanisms of how tacrolimus ointment induces repigmentation in patients with vitiligo[J]. Br J Dermatol, 2005, 153(3): 498-505.
2. Kang HY, Choi YM. FK506 increases pigmentation and migration of human melanocytes[J]. Br J Dermatol, 2006, 155(5):1037-1040.
3. Tanghetti EA. Tacrolimus ointment 0.1% produces repigmentation in patients with vitiligo:results of a prospective patientseries [J]. Cutis, 2003, 71(2): 158-162.